Teva Caves In Under FTC Pressure And Orders The Removal Of Improper Inhaler Patent Listings

Over 200 Patents Were Requested To Be Removed

Website of the US Federal Trade Commission
(Shutterstock)

More from Legal & IP

More from Generics Bulletin